Impaired glucose metabolism in colorectal cancer

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 9, 2006, Pages 1079-1086

  Ehrmann Jósko, Agnieszka ^a   Siemińska, Jolanta ^a   Górnicka, Barbara ^a   Ziarkiewicz Wróblewska, Bogna ^a   Ziółkowski, Bartłomiej ^a   Muszyński, Jacek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Colorectal cancer; diabetes

Indexed keywords

BIOLOGICAL MARKER; C PEPTIDE; INSULIN;

ADULT; AGED; ARTICLE; BLOOD; COLORECTAL TUMOR; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-PEPTIDE; COLORECTAL NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34247607342     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520600587444     Document Type: Article

References (37)

1. Maynard GD. Statistical study in cancer death rates. Biometrica 1910; 7: 276–304
2. Doering CR. Statistical methods. Preventive medicine and hygiene6th ed, CR Rosenau. Appelton Century, New York 1935; 1221–60
3. Wilson EB, Maher HC. Cancer and tuberculosis with some comments on cancer and other diseases. Am J Cancer 1932; 16: 227–50
4. Weiderpass E, Gridley G, Nyren O, Berne C, Linet MS, Ekbom A, et al. Diabetes mellitus and risk of large bowel cancer. J Ntl Cancer Inst 1997; 89: 660–1
5. Williams JC, Walsh DA, Jackson JF. Colon carcinoma and diabetes mellitus. Cancer 1984; 54: 3070–1
6. Muszyński J, Jóźwicka E, Szadkowski A. Zaburzenia tolerancji węglowodanów u chorych na raka jelita grubego. Pol Tyg Lek 1990; 45: 1005–7
7. Joslin EP, Lombard LH, Burrows RE. Diabetes and cancer. N Engl J Med 1959; 262: 486–8
8. Czyżyk, A. Patofizjologia i klinika cukrzycy. PWN Warszawa 1997.
9. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the US. Diabetes 2002; 51: 2170–8
10. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542–7
11. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy K, Dechaud H, et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592–600
12. La Vecchia C, Negri E, Decarli A, Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1997; 6: 1007–10
13. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950–3
14. Le Marchand L, Wilkens LR, Kolonel LN. Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes mellitus with the risk of colorectal cancer. Cancer Res 1997; 57: 4787–94
15. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women: 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990; 131: 254–62
16. Will JC, Galuska DA, Vinicor F, Calle E. Colorectal cancer: another complication of diabetes mellitus?. Am J Epidemiol 1998; 147: 816–25
17. Young-In Kim. Diet, lifestyle and colorectal cancer: is hyperinsulinemia the missing link?. Nutr Rev 1998; 56: 275–9
18. Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K. Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 1997; 26: 144–53
19. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997; 71: 360–3
20. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88: 1472–7
21. Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in northern Italy. Eur J Cancer 1997; 33: 629–34
22. Salazar-Martinez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De Rios P, Salmeron-Castro J, Larrea F, et al. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000; 11: 707–11
23. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Bar JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 185–92
24. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307–14
25. Lindblad P, Chow WH, Chan J, Bergstrom A, Wolk A, Gridley G, et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999; 42: 107–12
26. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Ins 1997; 89: 1360–5
27. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990; 39: 40–6
28. Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol 2003; 157: 1092–100
29. Colangelo L, Gapstur S, Gann P, Dyer AR, Kiang Liu. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385–91
30. Sandhu MS, Luben R, Khaw KT. Self-reported non-insulin dependent diabetes, family history, and risk of prevalent colorectal cancer: population-based, cross-sectional study. J Epidemiol Community Health 2001; 55: 804–5
31. Kono S, Honjo S, Todoroki I, Nishiwaki M, Hamada H, Nishikawa H, et al. Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 1998; 9: 441–6
32. Nishii T, Kono S, Abe H, Eguchi H, Shimazaki K, Hatano B, et al. Glucose intolerance, plasma insulin levels, and colon adenomas in Japanese men. Jpn J Cancer Res 2001; 92: 836–40
33. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985; 38: 435–41
34. Mc Keown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?. Cancer Epidemiol Biomarkers Prev 1994; 3: 687–95
35. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995; 6: 164–79
36. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131 Suppl 11: 3109S–20S
37. Yu H, Rohan T. The role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 1472–89